Asthma & COPD
Functional lung imaging offers new possibilities for respiratory care
August 9, 2026Data Capture Asthma & COPD, Computed tomography, Diagnostics, digital technologies, medical imaging
Advances in computed tomography (CT) technology are helping to reshape the diagnosis and management of chronic respiratory disease, with new …
Andera Partners leads financing for asthma treatment company Spiro Medical
January 5, 2026Sales and Marketing Andera Partners, Asthma & COPD, Spiro Medical
Andera Partners, a private equity firm, has announced its leadership of a $67m series A financing round in Spiro Medical, …
GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis
December 16, 2025Regulatory Affairs, Research and Development Asthma & COPD, GSK
GSK’s Exdensur (depemokimab), a twice-yearly biological medicine, has received approval from the UK Medicines and Healthcare products Regulatory Agency (MHRA) …
electronRx to launch pDx app for remote monitoring of chronic respiratory disease
September 18, 2025Research and Development Asthma & COPD, Devices, devices, electronRx, pDx, respiratory diseases (CRDs)
Digital medicine company electronRx, based in Cambridge, UK, has announced the upcoming launch of pDx, a mobile app designed to …
GSK shares positive results from phase 3 asthma trials
May 21, 2024Research and Development Asthma & COPD, GSK, asthma, clinical trial
GSK has announced positive headline results from its phase 3 SWIFT-1 and SWIFT-2 trials, which evaluated the safety and efficacy …
GSK’s low carbon inhaler, Ventolin, progresses to phase 3 trialsÂ
November 21, 2023Medical Communications Asthma & COPD, GSK, Ventolin, asthma, carbon-neutral
GSK has announced that in 2024 it intends to start phase 3 trials of a low carbon version of its …
Lupin Healthcare launches Beclu carbon neutral inhalers for asthma treatment
June 22, 2023Research and Development Asthma & COPD, Beclu, Lupin Healthcare, asthma, carbon neutral, inhaler
UK-based subsidiary of Lupin Limited, Lupin Healthcare, has announced the UK launch of its carbon neutral pressurised metered dose inhalers …
Latest content
Scots neonatal innovations target hearing loss and earlier care
Agentis Health Group acquires Clinical Pharmacist Solutions
